@uroegg I believe what you are looking for is some comparison of usual of care salvage treatment versus PSMA-directed salvage treatment. Data are sparse at the moment and lots of caveats, but hopefully this trial sheds some light on the question in the fut
RT @CalaisJeremie: @DrMHofman @DrAIravani @drlouiseemmett @PCF_Science @PCFA @PCFnews @pros_tic @declangmurphy @thomashopemd response will…
RT @CalaisJeremie: @DrAIravani @DrMHofman @drlouiseemmett @PCF_Science @PCFA @PCFnews @pros_tic @declangmurphy @thomashopemd response will…
@DrAIravani @DrMHofman @drlouiseemmett @PCF_Science @PCFA @PCFnews @pros_tic @declangmurphy @thomashopemd response will come from here ! https://t.co/t8BNMclBPI
@DrMHofman @DrAIravani @drlouiseemmett @PCF_Science @PCFA @PCFnews @pros_tic @declangmurphy @thomashopemd response will com from here https://t.co/t8BNMclBPI https://t.co/4Yra5XrqLk
@cpeedell @DrSpratticus @Prof_Nick_James A biomarker-like approach would be nice here either randomizing like this trial: https://t.co/pdtMPaa0Bw or as suggested by @EORTC https://t.co/w1Ko7QeipX or as an alternative blinding clinicians from the result.